Masahiro Shin
- Cell Biology top 2%
- Zebrafish Biomedical Research Applications 10
- Aging top 5%
- Molecular Biology top 10%
- Congenital heart defects research 6
- CRISPR and Genetic Engineering 6
- Fibroblast Growth Factor Research 4
- Angiogenesis and VEGF in Cancer 4
- Pluripotent Stem Cells Research 2
-
- Lymphatic System and Diseases 5
-
- Erythrocyte Function and Pathophysiology 3
- Co-authors
- Nathan D. LawsonIra MaleFatma O. KokScot A. WolfeGuojun ShengAnkit GuptaHiroki NagaiAnn S. Grosse
- Cited by
- Cell BiologyAgingMolecular Biology
- Partner nations
- United StatesJapanGermany
In The Last Decade
Masahiro Shin
28 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Cell Biology 547
- Aging 40
- Molecular Biology 1.2k
- Business and International Management 22
- Cellular and Molecular Neuroscience 142
Countries citing papers authored by Masahiro Shin
This map shows the geographic impact of Masahiro Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Shin more than expected).
Fields of papers citing papers by Masahiro Shin
This network shows the impact of papers produced by Masahiro Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Shin. The network helps show where Masahiro Shin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masahiro Shin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 11 | |
| 5 | 2021 | 38 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 28 | |
| 8 | 2020 | 67 | |
| 9 | 2019 | 32 | |
| 10 | 2018 | 13 | |
| 11 | 2017 | 37 | |
| 12 | 2013 | 85 | |
| 13 | 2011 | 27 | |
| 14 | 2008 | 16 | |
| 15 | 2008 | 17 | |
| 16 | 2007 | 68 | |
| 17 | 2006 | 19 | |
| 18 | 2006 | 11 | |
| 19 | 2005 | 15 | |
| 20 | 2003 | 2 |
About Masahiro Shin
Masahiro Shin is a scholar working on Aging, Cell Biology, Molecular Biology, Hematology and Virology, having authored 30 papers that have together received 1.6k indexed citations. Recurring topics across this work include Zebrafish Biomedical Research Applications (10 papers), Congenital heart defects research (6 papers), CRISPR and Genetic Engineering (6 papers), Lymphatic System and Diseases (5 papers), Fibroblast Growth Factor Research (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Pluripotent Stem Cells Research (2 papers). The work is most often cited by research in Cell Biology (547 citations), Aging (40 citations), Molecular Biology (1.2k citations), Business and International Management (22 citations) and Cellular and Molecular Neuroscience (142 citations). Masahiro Shin has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Nathan D. Lawson, Ira Male, Fatma O. Kok, Scot A. Wolfe, Guojun Sheng, Ankit Gupta, Hiroki Nagai, Ann S. Grosse, Lihua Julie Zhu and Christer Betsholtz. Their work appears in journals such as Development, Developmental Cell, eLife, Developmental Dynamics and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.